scADGFP
(Plasmid
#114434)
-
PurposeEpilepsy promoter enhanced with Arc elements driving GFP with SV40E polyA
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 114434 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepLVUTH
- Backbone size w/o insert (bp) 4266
- Total vector size (bp) 6578
-
Modifications to backboneLentiviral LTRs replaced with AAV ITRs and deletion of 5' CMV promoter
-
Vector typeMammalian Expression, AAV
-
Selectable markersZeocin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameGreen fluorescent protein
-
Alt nameeGFP-ERX
-
SpeciesSynthetic
-
Insert Size (bp)743
- Promoter Novel synthetic activity-dependent promoter
-
Tag
/ Fusion Protein
- ER export sequence FCYENEV (C terminal on insert)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site PacI (not destroyed)
- 3′ cloning site AgeI (destroyed during cloning)
- 5′ sequencing primer AAGGGCGACACGGAAATG
- 3′ sequencing primer TCCGCCTCAGAAGCCATAGA (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
scADGFP was a gift from Edward Perez-Reyes (Addgene plasmid # 114434 ; http://n2t.net/addgene:114434 ; RRID:Addgene_114434) -
For your References section:
EpiPro, a Novel, Synthetic, Activity-Regulated Promoter That Targets Hyperactive Neurons in Epilepsy for Gene Therapy Applications. Burke CT, Vitko I, Straub J, Nylund EO, Gawda A, Blair K, Sullivan KA, Ergun L, Ottolini M, Patel MK, Perez-Reyes E. Int J Mol Sci. 2023 Sep 23;24(19):14467. doi: 10.3390/ijms241914467. 10.3390/ijms241914467 PubMed 37833914